Summit Therapeutics (SMMT) - 2018 Q4 - Earnings Call Transcript

Summit Therapeutics plc (NASDAQ:SMMT) Q4 2018 Results Conference Call March 27, 2019 8:00 AM ET Company Participants Richard Pye - VP, Corporate Affairs Glyn Edwards - CEO Melissa Strange - VP, Finance Conference Call Participants Hartaj Singh - Oppenheimer & Company Tim Chiang - BTIG Joseph Hedden - Rx Securities Yun Zhong - Janney Gary Waanders - Bryan Garnier Julie Simmonds - Panmure Gordon Dewey Steadman - Canaccord Operator Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to tod ...